WebThis system is the property of GlaxoSmithKline and may only be accessed by authorized users. By using this system you agree that GSK and its authorized agents may monitor, intercept, read, copy, capture and record any data and communications that occur on GSK IT Resources (including email and other electronic traffic to and from the Internet). WebPlease try the recommended action below. Refresh the application. Fewer Details

Log Into Your GSKPro Account GSKPro for Healthcare Professionals

WebApr 10, 2024 · GSK is beefing up its infectious disease portfolio with an antifungal from Scynexis. For $90 million up front and possible milestone-based payments up to $503 million, the pharma giant will get the rights to commercialize and further develop Scynexis’s antifungal Brexafemme (ibrexafungerp). The small-molecule treatment is approved by … WebLogin Where we operate You are currently visiting our global website. The subsequent websites and web pages are intended for non-UK audiences. Content is provided for the market's home audience and may not align with UK regulations. Remember Me Europe Belgium (FR) Belgium (NL) France/Dom Tom (FR) Germany (DE) Greece (EL) Italy (IT) … chart place holders

TotalRewards - powered by LifeWorks

WebLog Into Your GSKPro Account GSKPro for Healthcare Professionals. Login Register. GSK Products. Therapy Areas. Resources. Webinars. Contact Us. WebGSK AppConnect Service. This service provides access to select GSK applications. Unauthorized use is prohibited. If you are an authorized user, click the button beside the … WebAt GSK, we all take clear ownership of our work, giving and receiving constructive feedback, with the promise of reward and recognition for great performance. Helping everyone to … cursed g-l gmod